Home › Diffuse Large B-Cell Lymphoma › North Carolina › Charlotte
Diffuse Large B-Cell Lymphoma clinical trials in Charlotte, NC
4 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RecruitingPhase 2
- Novant Health Presbyterian Medical Center ( Site 0177), Charlotte
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecruitingPhase 2
- Novant Health Cancer Institute- Hematology, Charlotte
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- Levine Cancer Institute, Charlotte
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RecruitingPhase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Los Angeles, CA17 studies
- Houston, TX17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Portland, OR15 studies
- Philadelphia, PA15 studies
- Nashville, TN14 studies
- Durham, NC14 studies
- Dallas, TX13 studies
Other studies in Charlotte
- Cancer (all types)27 studies
- Breast Cancer22 studies
- Multiple Myeloma21 studies
- Non-Small Cell Lung Cancer19 studies
- Obesity17 studies
- Overweight16 studies
- Acute Myeloid Leukemia16 studies
- Colorectal Cancer13 studies
- Ovarian Cancer13 studies
- Heart Failure11 studies
- Metastatic Cancer11 studies
- Head and Neck Squamous Cell Carcinoma10 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.